News
Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...
As you would probably expect from such a well-known name connected to the healthcare industry, the goals for GSK for this new ...
GSK’s Blenrep combos are being reviewed in 14 nations. Credit: Magda Wygralak/Shutterstock. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for ...
The British multinational pharmaceutical and biotechnology company GSK has officially opened its new regional vaccine distribution centre in Abu Dhabi to serve the demand across the Gulf ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in ...
Today, a brief rundown of news involving GSK and Bristol Myers Squibb, as well as updates from Elevation Oncology, Bayer and Airna that you may have missed. Over the past 10 years, PD1-blocking ...
The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the drug’s first approval worldwide ...
(Alliance News) - GSK PLC on Thursday said it has received authorisation from the UK Medicines & Healthcare products Regulatory Agency for Blenrep combinations in the treatment of adults with ...
Speaking to Bloomberg last week, GSK CEO Emma Walmsley said the UK-based company has been keen to maximise opportunity in the US, which “has been the priority for investment”. But she but also ...
GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results